Myomo (MYO) Total Debt (2017 - 2025)
Myomo (MYO) posted Total Debt of $14.0 million for Q4 2025, up 365.18% on a QoQ basis from $3.0 million in Q3 2025, and up 24.36% year-over-year from $11.2 million in Q4 2024.
Myomo (MYO) Total Debt (2017 - 2025) Analysis & Trends
Myomo's Total Debt history runs 5 years deep, the most recent figure standing at $14.0 million for Q4 2025.
- Quarterly Total Debt rose 24.36% year-over-year to $14.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.0 million (up 24.36% YoY) and the FY2025 annual result came in at $14.0 million, up 24.36% from the prior year.
- Total Debt was $14.0 million for Q4 2025 at Myomo, up from $3.0 million in the prior quarter.
- Across five years, Total Debt topped out at $14.0 million in Q4 2025 and bottomed at $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 34.05 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.72 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 27.96 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 11.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.48 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.14 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | 13.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.96 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.83 Mn |
| Dec 31, 2024 | 11.22 Mn |
| Jun 30, 2020 | 77,892.00 |
| Mar 31, 2020 | 1.43 Mn |
| Dec 31, 2019 | 2.65 Mn |
| Dec 31, 2017 | 750,000.00 |
| Sep 30, 2017 | 876,458.00 |
| Jun 30, 2017 | 876,458.00 |